相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis
Patrick Weydt et al.
ANNALS OF NEUROLOGY (2016)
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD
Emily Feneberg et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers
Fabiola Puentes et al.
BRAIN PATHOLOGY (2016)
Emerging molecular biomarker targets for amyotrophic lateral sclerosis
Julia Costa et al.
CLINICA CHIMICA ACTA (2016)
CRYPTIC POLYGLUTAMINE REPEAT SEQUENCE VARIATION AND SOMATIC INSTABILITY IN HUNTINGTON'S DISEASE: DRIVERS OF PATHOLOGY?
Darren Monckton et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
Patrick Oeckl et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases
Annemarie Huebers et al.
NEUROBIOLOGY OF AGING (2014)
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation
A. Alberici et al.
NEUROLOGICAL SCIENCES (2014)
Progranulin protein levels are differently regulated in plasma and CSF
Alexandra M. Nicholson et al.
NEUROLOGY (2014)
Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
Laura Robelin et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chio et al.
NEUROEPIDEMIOLOGY (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Markus Otto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Progranulin: An emerging target for FTLD therapies
Jennifer Gass et al.
BRAIN RESEARCH (2012)
Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology
Paul G. Ince et al.
ACTA NEUROPATHOLOGICA (2011)
S100B protein in neurodegenerative disorders
Johann Steiner et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
Petra Steinacker et al.
PLOS ONE (2011)
Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration
Thomas Philips et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
CSF glial markers correlate with survival in amyotrophic lateral sclerosis
S. D. Suessmuth et al.
NEUROLOGY (2010)
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Angela S. Laird et al.
PLOS ONE (2010)
ALS and FTLD: two faces of TDP-43 proteinopathy
R. M. Liscic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
R. Ghidoni et al.
NEUROLOGY (2008)
Progranulin genetic variability contributes to amyotrophic lateral sclerosis
K. Sleegers et al.
NEUROLOGY (2008)
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes
J. C. Schymick et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
分享论文
